ORBIMED ADVISORS LLC – Bristol-Myers Squibb Company Transaction History
ORBIMED ADVISORS LLC portfolio value:
$183.76M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.63% | 66.2K shares | -10.17M | $71.09 | 2.58M |
| Q2 2022 | share | Decrease | -3.41% | -89K shares | 3.5M | $77 | 2.51M |
| Q1 2022 | share | Decrease | -39.91% | -1.73M shares | -80.14M | $73.03 | 2.60M |
| Q4 2021 | share | Decrease | -3.89% | -175.6K shares | 3.41M | $62.52 | 4.33M |
| Q3 2021 | share | 0.00% | 0 shares | -34.54M | $59.17 | 4.51M | |
| Q2 2021 | share | 0.00% | 0 shares | 16.66M | $65.79 | 4.51M | |
| Q1 2021 | share | Increase | +27.23% | 966.3K shares | 64.90M | $62.15 | 4.51M |
| Q4 2020 | share | 0.00% | 0 shares | 6.17M | $60.6 | 3.54M | |
| Q3 2020 | share | Increase | +23.14% | 666.9K shares | 44.50M | $58 | 3.54M |
| Q2 2020 | share | Increase | +16.46% | 407.4K shares | 31.52M | $56.14 | 2.88M |
| Q1 2020 | share | Increase | +45.58% | 774.8K shares | 28.82M | $52.79 | 2.47M |
| Q4 2019 | share | Increase | 0.00% | 1.7M shares | 109.12M | $60.36 | 1.7M |
| Q3 2019 | call | Decrease | -100.00% | -500K shares | -22.67M | $47.3 | 0 |
| Q3 2019 | share | Decrease | -100.00% | -1.34M shares | -61.00M | $47.3 | 0 |
| Q2 2019 | share | Increase | +12.57% | 150.2K shares | 3.99M | $41.93 | 1.34M |
| Q2 2019 | call | Increase | 0.00% | 500K shares | 22.67M | $41.93 | 500K |
| Q1 2019 | share | Increase | +136.21% | 689.1K shares | 30.71M | $43.73 | 1.19M |
| Q4 2018 | share | Decrease | -75.03% | -1.51M shares | -99.46M | $47.21 | 505.9K |
| Q3 2018 | share | Decrease | -14.89% | -354.5K shares | -5.96M | $56.02 | 2.02M |
| Q2 2018 | share | Decrease | -35.24% | -1.29M shares | -100.73M | $49.59 | 2.38M |
| Q2 2018 | call | Decrease | -100.00% | -200K shares | -12.65M | $49.59 | 0 |
| Q1 2018 | call | Increase | 0.00% | 200K shares | 12.65M | $56.31 | 200K |
| Q1 2018 | share | Increase | +434.20% | 2.98M shares | 190.30M | $56.31 | 3.67M |
| Q4 2017 | share | Decrease | -21.34% | -186.7K shares | -13.59M | $54.21 | 688K |
| Q4 2017 | call | Decrease | -100.00% | -150K shares | -9.56M | $54.21 | 0 |
| Q3 2017 | call | Increase | 0.00% | 150K shares | 9.56M | $56.04 | 150K |
| Q3 2017 | share | 0.00% | 0 shares | 7.01M | $56.04 | 874.7K | |
| Q2 2017 | put | Decrease | -100.00% | -200K shares | -10.87M | $48.65 | 0 |
| Q2 2017 | share | Decrease | -54.23% | -1.03M shares | -55.18M | $48.65 | 874.7K |
| Q2 2017 | call | Decrease | -100.00% | -100K shares | -5.43M | $48.65 | 0 |
| Q1 2017 | put | Increase | 0.00% | 200K shares | 10.87M | $47.14 | 200K |
| Q1 2017 | call | Increase | 0.00% | 100K shares | 5.43M | $47.14 | 100K |
| Q1 2017 | share | Increase | +27.95% | 417.5K shares | 16.64M | $47.14 | 1.91M |
| Q4 2016 | call | Decrease | -100.00% | -100K shares | -5.39M | $50.32 | 0 |
| Q4 2016 | share | Decrease | -31.72% | -693.9K shares | -30.66M | $50.32 | 1.49M |
| Q3 2016 | share | Decrease | -56.73% | -2.86M shares | -253.89M | $46.11 | 2.18M |
| Q3 2016 | call | Increase | 0.00% | 100K shares | 5.39M | $46.11 | 100K |
| Q2 2016 | share | Decrease | -33.70% | -2.56M shares | -115.24M | $62.9 | 5.05M |
| Q1 2016 | share | Decrease | -9.17% | -770.1K shares | -90.41M | $54.35 | 7.62M |